Advanced Search
Contact | Corporate | Help

Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

Sponsors:
  • University of Pittsburgh
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Pemetrexed
  • Drug: Bevacizumab
Enrollment:
20

Additional information about NCT00222729.


SourceSolution © 2008-2012